Northern Trust’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
107,568
-79,398
| -42% | -$88.9K | ﹤0.01% | 4071 |
|
|
2025
Q1 | $215K | Sell |
186,966
-6,019
| -3% | -$6.92K | ﹤0.01% | 3922 |
|
|
2024
Q4 | $1.18M | Buy |
192,985
+1,312
| +0.7% | +$8.02K | ﹤0.01% | 3317 |
|
|
2024
Q3 | $3.17M | Buy |
191,673
+56,946
| +42% | +$942K | ﹤0.01% | 2725 |
|
|
2024
Q2 | $926K | Sell |
134,727
-2,509
| -2% | -$17.2K | ﹤0.01% | 3281 |
|
|
2024
Q1 | $1.32M | Buy |
137,236
+440
| +0.3% | +$4.25K | ﹤0.01% | 3181 |
|
|
2023
Q4 | $1.14M | Buy |
136,796
+1,013
| +0.7% | +$8.42K | ﹤0.01% | 3269 |
|
|
2023
Q3 | $1.13M | Buy |
135,783
+15,009
| +12% | +$125K | ﹤0.01% | 3250 |
|
|
2023
Q2 | $1.11M | Buy |
120,774
+1,974
| +2% | +$18.2K | ﹤0.01% | 3319 |
|
|
2023
Q1 | $1.63M | Sell |
118,800
-1,248
| -1% | -$17.1K | ﹤0.01% | 3026 |
|
|
2022
Q4 | $2.04M | Buy |
120,048
+6,399
| +6% | +$109K | ﹤0.01% | 2983 |
|
|
2022
Q3 | $2.58M | Buy |
113,649
+3,043
| +3% | +$69.2K | ﹤0.01% | 2879 |
|
|
2022
Q2 | $1.99M | Buy |
110,606
+25,934
| +31% | +$468K | ﹤0.01% | 3072 |
|
|
2022
Q1 | $2.26M | Buy |
84,672
+7,128
| +9% | +$191K | ﹤0.01% | 3041 |
|
|
2021
Q4 | $2.28M | Sell |
77,544
-2,970
| -4% | -$87.1K | ﹤0.01% | 3164 |
|
|
2021
Q3 | $5.3M | Sell |
80,514
-21,740
| -21% | -$1.43M | ﹤0.01% | 2692 |
|
|
2021
Q2 | $8.51M | Sell |
102,254
-877
| -0.9% | -$73K | ﹤0.01% | 2485 |
|
|
2021
Q1 | $7.91M | Sell |
103,131
-11,738
| -10% | -$900K | ﹤0.01% | 2454 |
|
|
2020
Q4 | $10.1M | Sell |
114,869
-5,078
| -4% | -$448K | ﹤0.01% | 2241 |
|
|
2020
Q3 | $8.85M | Sell |
119,947
-15,605
| -12% | -$1.15M | ﹤0.01% | 2180 |
|
|
2020
Q2 | $9.9M | Buy |
135,552
+45,692
| +51% | +$3.34M | ﹤0.01% | 2103 |
|
|
2020
Q1 | $5.05M | Buy |
89,860
+17,183
| +24% | +$965K | ﹤0.01% | 2298 |
|
|
2019
Q4 | $2.77M | Buy |
+72,677
| New | +$2.77M | ﹤0.01% | 2930 |
|